STREAMEX CORP. Operating Lease, Right-of-Use Asset, Amortization Expense
STREAMEX CORP. (STEX) had Operating Lease, Right-of-Use Asset, Amortization Expense of $42.31 thousand as of 2022-04-04, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2023-03-31
- STREAMEX CORP. operating lease, right-of-use asset, amortization expense for the quarter ending 2021-09-30 was $104.00K, a 9.57% decline year-over-year.
- STREAMEX CORP. operating lease, right-of-use asset, amortization expense for the quarter ending 2020-09-30 was $115.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month |
|---|---|---|---|---|
| 2022-04-04 | $42.31K 10-Q · filed 2022-11-14 | |||
| 2021-09-30 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $334.00K 10-Q · filed 2021-11-15 | ||
| 2021-08-03 | $36.76K 10-K · filed 2023-03-31 | |||
| 2021-08-02 | $10.25K 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $230.00K 10-Q · filed 2021-08-11 | |||
| 2021-02-10 | $60.88K 10-Q · filed 2021-11-15 | |||
| 2020-09-30 | $115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $342.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $227.00K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |